References
- Schmiegelow K, Attarbaschi A, Barzilai S, et al. Consensus definitions of 14 severe acute toxic effects for childhood lymphoblastic leukaemia treatment: a Delphi consensus. Lancet Oncol. 2016;17:e231–e239.
- Pui CH, Yang JJ, Hunger SP, et al. Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol. 2015;33:2938–2948.
- Kawedia JD, Kaste SC, Pei D, et al. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood. 2011;117:2340–2347. quiz 556.
- Mattano LA Jr, Devidas M, Nachman JB, et al. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13:906–915.
- Mattano LA Jr, Sather HN, Trigg ME, et al. Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children’s Cancer Group. J Clin Oncol. 2000;18:3262–3272.
- Möricke A, Zimmermann M, Valsecchi MG, et al. Dexamethasone vs. prednisone in induction treatment of pediatric ALL: results of the randomized trial AIEOP-BFM ALL 2000. Blood. 2016;127:2101–2112.
- Niinimaki RA, Harila-Saari AH, Jartti AE, et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol. 2007;25:1498–1504.
- Padhye B, Dalla-Pozza L, Little D, et al. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Med. 2016;5:960–967.
- Relling MV, Yang W, Das S, et al. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia. J Clin Oncol. 2004;22:3930–3936.
- Sharma S, Yang S, Rochester R, et al. Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT. Bone Marrow Transpl. 2011;46:813–819.
- te Winkel ML, Pieters R, Hop WC, et al. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2011;29:4143–4150.
- Kuhlen M, Moldovan A, Krull K, et al. Osteonecrosis in paediatric patients with acute lymphoblastic leukaemia treated on Co-ALL-07-03 trial: a single centre analysis. Klin Padiatr. 2014;226:154–160.
- Kunstreich M, Kummer S, Laws HJ, et al. Osteonecrosis in children with acute lymphoblastic leukemia. Haematologica. 2016;101:1295–1305.
- Hino M, Yamane T, Ohta K, et al. Bone resorption associated with uncoupling of osteoclastic and osteoblastic activities in adult T cell leukemia with hypercalcemia: case report. Ann Hematol. 2001;80:426–429.
- Soni PN. Hypercalcaemia and multiple osteolytic lesions in childhood acute lymphoblastic leukaemia. Postgrad Med J. 1993;69:483–485.
- ARCO (Association Research Circulation Osseous): committee on terminology and classification. ARCO News. 1992;4:41–46.
- Kaste SC, Pei D, Cheng C, et al. Utility of early screening magnetic resonance imaging for extensive hip osteonecrosis in pediatric patients treated with glucocorticoids. J Clin Oncol. 2015;33:610–615.
- Ribeiro RC, Fletcher BD, Kennedy W, et al. Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma. Leukemia. 2001;15:891–897.
- Strauss AJ, Su JT, Dalton VM, et al. Bony morbidity in children treated for acute lymphoblastic leukemia. J Clin Oncol. 2001;19:3066–3072.
- Bohndorf K, Benz-Bohm G, Gross-Fengels W, et al. MRI of the knee region in leukemic children. Part I. Initial pattern in patients with untreated disease. Pediatr Radiol. 1990;20:179–183.
- Ojala AE, Paakko E, Lanning FP, et al. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol. 1999;32:11–17.
- Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26:3038–3045.
- Kaste SC. Skeletal toxicities of treatment in children with cancer. Pediatr Blood Cancer. 2008;50:469–473; discussion 86.
- Kaste SC, Karimova EJ, Neel MD. Osteonecrosis in children after therapy for malignancy. Am J Roentgenol. 2011;196:1011–1018.
- Benz-Bohm G, Gross-Fengels W, Bohndorf K, et al. MRI of the knee region in leukemic children. Part II. Follow up: responder, non-responder, relapse. Pediatr Radiol. 1990;20:272–276.
- Kretschmer A, Ballof U, Graf N, et al. [The diagnosis of bone marrow lesions in the MR tomogram in children with diseases of the hematopoietic system with special reference to post-therapy changes]. RoFo. 1992;156:570–575.
- Sansgiri RK, Neel MD, Soto-Fourier M, et al. Unique MRI findings as an early predictor of osteonecrosis in pediatric acute lymphoblastic leukemia. Am J Roentgenol. 2012;198:W432–W439.